Sign inJoin waitlistJoin the waitlist

Darcy Spicer

Chief of the Division of Medical Oncology · University of Southern California/Los Angeles General Medical Center

Credentials: · · · ·

History

Division of Medical Oncology · University of Southern California/Los Angeles General Medical Center
Present
Lynne Cohen Clinic · University of Southern California/Los Angeles General Medical Center
Present
Division of Oncology · University of Southern California/Los Angeles General Medical Center
Present

Medical Oncology
1979–1981
Montreal General Hospital
1976–1979
Western University
1975–1976
Doctor of Medicine
1971–1975

Research

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
Review · Epidemiologic Reviews · 1993 · 841 citations
Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer
Journal of Clinical Oncology · 1997 · 496 citations
Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized…
Journal of Clinical Oncology · 2018 · 284 citations

Nathalie Sami
9 papers · 2 as a resident
Thomas Buchanan
8 papers
Heinz-Josef Lenz
7 papers
JM
Joanne Mortimer
7 papers
Silvia Formenti
7 papers
Debra Hawes
5 papers · 2 as a fellow
Donna Shoupe
5 papers
FM
Franco Muggia
5 papers
KS
Kristin Skinner
5 papers
MP
Michael Press
5 papers
BF
Barbara Florentine
4 papers
HS
Howard Silberman
4 papers

Grants

SCCISARS 2: An e-Solution to Protect Human Subjects
National Center for Research Resources · S07
Contact PI · $350K · University of Southern California
2002–2006
University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)
National Cancer Institute · P30
Project lead · $91.6K · University of Southern California
1980–2005
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $682.9K · University of Southern California
1997–2001
Gnrh Agonist Regimen for Breast Cancer Prevention
National Cancer Institute · U01
Contact PI · $196.3K · Balance Pharmaceuticals, Inc.
1998–2000

Clinical trials

Pilot Trial of XFBD, a TCM, in Persons With COVID-19
Principal investigator · Terminated · Phase 2
Darcy Spicer
2021–2022
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
Principal investigator · Terminated · Phase 2
University of Southern California
2013–2021
Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer
Principal investigator · Active not recruiting
University of Southern California
2013–2027
Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer
Study chair · Completed · Phase 2
University of Southern California
1997–2000